Amgen Total Liabilities 2006-2019 | AMGN

Amgen total liabilities from 2006 to 2019. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Amgen total liabilities for the quarter ending September 30, 2019 were $48.608B, a 8.26% decline year-over-year.
  • Amgen total liabilities for 2018 were $53.916B, a 1.46% decline from 2017.
  • Amgen total liabilities for 2017 were $54.713B, a 14.58% increase from 2016.
  • Amgen total liabilities for 2016 were $47.751B, a 10.11% increase from 2015.
Amgen Annual Total Liabilities
(Millions of US $)
2018 $53,916
2017 $54,713
2016 $47,751
2015 $43,366
2014 $43,231
2013 $44,029
2012 $35,238
2011 $29,842
2010 $19,542
2009 $16,962
2008 $15,542
2007 $16,770
2006 $14,824
2005 $8,846
Amgen Quarterly Total Liabilities
(Millions of US $)
Q3 2019 $48,608
Q2 2019 $48,579
Q1 2019 $53,165
Q4 2018 $53,916
Q3 2018 $52,984
Q2 2018 $52,775
Q1 2018 $55,544
Q4 2017 $54,713
Q3 2017 $48,102
Q2 2017 $47,865
Q1 2017 $47,225
Q4 2016 $47,751
Q3 2016 $47,377
Q2 2016 $45,338
Q1 2016 $46,434
Q4 2015 $43,366
Q3 2015 $43,902
Q2 2015 $43,725
Q1 2015 $42,446
Q4 2014 $43,231
Q3 2014 $45,450
Q2 2014 $45,152
Q1 2014 $44,263
Q4 2013 $44,029
Q3 2013 $35,345
Q2 2013 $32,016
Q1 2013 $32,149
Q4 2012 $35,238
Q3 2012 $35,546
Q2 2012 $32,987
Q1 2012 $30,376
Q4 2011 $29,842
Q3 2011 $22,212
Q2 2011 $21,322
Q1 2011 $17,730
Q4 2010 $19,542
Q3 2010 $19,463
Q2 2010 $17,630
Q1 2010 $18,027
Q4 2009 $16,962
Q3 2009 $18,082
Q2 2009 $17,480
Q1 2009 $17,413
Q4 2008 $15,542
Q3 2008 $17,166
Q2 2008 $17,528
Q1 2008 $17,041
Q4 2007 $16,770
Q3 2007 $16,547
Q2 2007 $16,502
Q1 2007 $12,855
Q4 2006 $14,824
Q3 2006 $14,865
Q2 2006 $14,449
Q1 2006 $13,924
Q4 2005 $8,846
Q3 2005 $8,602
Q2 2005 $8,457
Q1 2005 $8,380
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $138.308B $23.747B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
CSL (CSLLY) Australia $85.405B 0.00
Gilead Sciences (GILD) United States $83.588B 10.36
Vertex Pharmaceuticals (VRTX) United States $56.863B 58.04
Biogen (BIIB) United States $52.454B 9.00
Illumina (ILMN) United States $47.477B 52.09
Regeneron Pharmaceuticals (REGN) United States $40.493B 17.73
Alexion Pharmaceuticals (ALXN) United States $25.238B 12.46
Seattle Genetics (SGEN) United States $20.383B 0.00
Incyte (INCY) United States $20.269B 47.05
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.513B 64.10
BioMarin Pharmaceutical (BMRN) United States $14.411B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.643B 0.00
Galapagos (GLPG) Belgium $11.053B 28.48
Exact Sciences (EXAS) United States $10.807B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
BeiGene (BGNE) Cayman Islands $9.600B 0.00
QIAGEN (QGEN) Netherlands $9.593B 31.28
Sarepta Therapeutics (SRPT) United States $8.297B 0.00
Bio-Techne Corp (TECH) United States $8.214B 54.98
Amarin (AMRN) Ireland $7.727B 0.00
Moderna (MRNA) United States $7.092B 0.00
Guardant Health (GH) United States $7.062B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.922B 0.00
Medicines (MDCO) United States $6.705B 0.00
Reata Pharmaceuticals (RETA) United States $6.134B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.042B 15.36
ARGENX SE-ADR (ARGX) Netherlands $5.609B 0.00
Exelixis (EXEL) United States $5.065B 14.25
Ascendis Pharma (ASND) Denmark $4.793B 0.00
Bluebird Bio (BLUE) United States $4.696B 0.00
China Biologic Products (CBPO) China $4.597B 25.90
Repligen (RGEN) United States $4.570B 82.82
Spark Therapeutics (ONCE) United States $4.272B 0.00
Mirati Therapeutics (MRTX) United States $4.133B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.037B 0.00
MorphoSys AG (MOR) Germany $3.985B 0.00
Blueprint Medicines (BPMC) United States $3.775B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.728B 0.00
Immunomedics (IMMU) United States $3.674B 0.00
Adaptive Biotechnologies (ADPT) United States $3.353B 0.00
Alkermes (ALKS) Ireland $3.191B 0.00
Genmab (GMAB) Denmark $3.064B 6.31
MyoKardia (MYOK) United States $3.029B 0.00
UniQure (QURE) Netherlands $2.788B 0.00
Emergent Biosolutions (EBS) United States $2.770B 27.52
Halozyme Therapeutics (HALO) United States $2.739B 0.00
Amicus Therapeutics (FOLD) United States $2.737B 0.00
NeoGenomics (NEO) United States $2.670B 142.06
Acceleron Pharma (XLRN) United States $2.593B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.401B 0.00
Zai Lab (ZLAB) China $2.354B 0.00
Arena Pharmaceuticals (ARNA) United States $2.301B 5.35
RA PHARMCTL INC (RARX) United States $2.215B 0.00
Insmed (INSM) United States $2.052B 0.00
Ligand Pharmaceuticals (LGND) United States $1.950B 37.50
Myriad Genetics (MYGN) United States $1.843B 27.23
Dicerna Pharmaceuticals (DRNA) United States $1.771B 0.00
Denali Therapeutics (DNLI) United States $1.702B 0.00
Zymeworks (ZYME) Canada $1.695B 0.00
REGENXBIO (RGNX) United States $1.638B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.634B 0.00
Akcea Therapeutics (AKCA) United States $1.623B 0.00
Editas Medicine (EDIT) United States $1.554B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.520B 0.00
Epizyme (EPZM) United States $1.448B 0.00
Alector (ALEC) United States $1.340B 0.00
Sangamo Therapeutics (SGMO) United States $1.318B 0.00
Innoviva (INVA) United States $1.314B 3.87
Arvinas (ARVN) United States $1.271B 0.00
Athenex (ATNX) United States $1.239B 0.00
Coherus BioSciences (CHRS) United States $1.226B 0.00
WAVE Life Sciences (WVE) Singapore $1.169B 0.00
Principia Biopharma (PRNB) United States $1.156B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.141B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Fate Therapeutics (FATE) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $0.974B 0.00
Revance Therapeutics (RVNC) United States $0.909B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.908B 7.64
ZIOPHARM Oncology Inc (ZIOP) United States $0.889B 0.00
Codexis (CDXS) United States $0.888B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.870B 0.00
Precision BioSciences (DTIL) United States $0.856B 0.00
Pharming Group (PHGUF) Netherlands $0.840B 0.00
Vericel (VCEL) United States $0.836B 311.83
Intellia Therapeutics (NTLA) United States $0.834B 0.00
Anika Therapeutics (ANIK) United States $0.812B 26.34
MiMedx (MDXG) United States $0.797B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.792B 0.00
Twist Bioscience (TWST) United States $0.748B 0.00
Heska (HSKA) United States $0.746B 190.58
ANI Pharmaceuticals (ANIP) United States $0.720B 12.27
Adverum Biotechnologies (ADVM) United States $0.691B 0.00
DBV Technologies S.A (DBVT) France $0.688B 0.00
Cara Therapeutics (CARA) United States $0.678B 0.00
UROGEN PHARMA (URGN) United States $0.660B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.650B 0.00
Clovis Oncology (CLVS) United States $0.640B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.629B 0.00
Mesoblast (MESO) Australia $0.616B 0.00
Cellectis S.A (CLLS) France $0.614B 0.00
Sorrento Therapeutics (SRNE) United States $0.614B 0.00
GENFIT S.A (GNFT) France $0.606B 0.00
BioDelivery Sciences (BDSI) United States $0.605B 0.00
Cytokineticsorporated (CYTK) United States $0.578B 0.00
Retrophin (RTRX) United States $0.564B 0.00
Agenus (AGEN) United States $0.552B 0.00
PHARMA MAR SA (PHMMF) Spain $0.549B 0.00
Kadmon Holdings (KDMN) United States $0.542B 0.00
Intra-Cellular Therapies (ITCI) United States $0.537B 0.00
AC Immune SA (ACIU) Switzerland $0.535B 12.38
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Stemline Therapeutics (STML) United States $0.502B 0.00
Prothena (PRTA) Ireland $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.387B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
Arcus Biosciences (RCUS) United States $0.377B 0.00
Puma Biotechnology (PBYI) United States $0.364B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
PDL BioPharma (PDLI) United States $0.354B 8.86
OSMOTICA PHARM (OSMT) United States $0.351B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.351B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.351B 2.43
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
Cellular Biomedicine (CBMG) United States $0.338B 0.00
Pfenex (PFNX) United States $0.334B 0.00
Avid Bioservices (CDMO) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.312B 0.00
Geron (GERN) United States $0.300B 0.00
Kindred Biosciences (KIN) United States $0.299B 0.00
CytomX Therapeutics (CTMX) United States $0.288B 0.00
Kamada (KMDA) Israel $0.287B 8.38
Cue Biopharma (CUE) United States $0.276B 0.00
Compugen (CGEN) Israel $0.274B 0.00
Cel-Sci (CVM) United States $0.267B 0.00
Albireo Pharma (ALBO) United States $0.266B 0.00
Seres Therapeutics (MCRB) United States $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.258B 0.00
Inovio Pharmaceuticals (INO) United States $0.255B 0.00
MannKind (MNKD) United States $0.254B 0.00
Scholar Rock Holding (SRRK) United States $0.246B 0.00
Exicure (XCUR) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Biofrontera AG (BFRA) Germany $0.232B 0.00
Theratechnologies (THTX) Canada $0.231B 0.00
Spero Therapeutics (SPRO) United States $0.215B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
ChromaDex (CDXC) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
Athersys (ATHX) United States $0.205B 0.00
Syros Pharmaceuticals (SYRS) United States $0.203B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.200B 0.00
Mersana Therapeutics (MRSN) United States $0.194B 0.00
Senesco Technologies (ELOX) United States $0.193B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.193B 0.00
Affimed (AFMD) Germany $0.186B 0.00
Palatin Technologies (PTN) United States $0.183B 4.99
IVERIC Bio (ISEE) United States $0.172B 0.00
ARAVIVE, INC (ARAV) United States $0.169B 0.00
Dyadic (DYAI) United States $0.168B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.159B 0.00
Cerecor (CERC) United States $0.157B 0.00
CorMedix Inc (CRMD) United States $0.155B 0.00
VBI Vaccines (VBIV) United States $0.154B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.152B 0.00
Five Prime Therapeutics (FPRX) United States $0.146B 0.00
Alcobra (ARCT) United States $0.145B 0.00
TELA Bio (TELA) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.140B 0.00
NantKwest (NK) United States $0.139B 0.00
Prometic Life Sciences (LMNL) Canada $0.137B 0.00
Proteostasis Therapeutics (PTI) United States $0.135B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.132B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Protagonist Therapeutics (PTGX) United States $0.128B 0.00
Novavax (NVAX) United States $0.127B 0.00
SESEN BIO, INC (SESN) United States $0.126B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Arsanis (XFOR) United States $0.126B 0.00
Celyad SA (CYAD) Belgium $0.122B 0.00
BioTime (LCTX) United States $0.120B 6.15
AVEO Pharmaceuticals (AVEO) United States $0.119B 0.00
Arbutus Biopharma (ABUS) Canada $0.114B 0.00
Verastem (VSTM) United States $0.106B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Emmaus Life Sciences (EMMA) United States $0.104B 0.00
OvaScience (MLND) United States $0.103B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Strongbridge Biopharma (SBBP) United States $0.099B 2.65
Acorda Therapeutics (ACOR) United States $0.099B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.099B 0.00
Aduro Biotech (ADRO) United States $0.095B 0.00
Adocia (ADOCY) France $0.086B 0.00
Antibe Therapeutics (ATBPF) Canada $0.084B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Liquidia Technologies (LQDA) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Catalyst Biosciences (CBIO) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Protalix BioTherapeutics (PLX) Israel $0.047B 0.00
Orgenesis (ORGS) United States $0.047B 3.03
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Evogene (EVGN) Israel $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
BioCardia (BCDA) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Aptevo Therapeutics (APVO) United States $0.029B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Entera Bio (ENTX) Israel $0.025B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Soligenix (SNGX) United States $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.020B 0.00
VistaGen Therapeutics (VTGN) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Advaxis (ADXS) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
IBio (IBIO) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.003B 0.00